Corcept Therapeutics Zoomed Nearly: What Fueled the Week
This week brought a notable rise for Corcept Therapeutics as investors reacted to a major catalyst. Learn what drove ...
A concise guide to spotting tax-friendly dividend ETFs, including key metrics and quick tips to boost after-tax performance.
22,830 articlesThis week brought a notable rise for Corcept Therapeutics as investors reacted to a major catalyst. Learn what drove ...
In a notable policy reversal, the Trump administration is weighing an executive order to create a government-industry...
Tesla is recalling more than 218,000 cars and SUVs due to a rearview camera delay that could impair reversing visibil...
A key Michigan district flipped Democrat in a special election, signaling rising concern over inflation and auto tari...
Investors noticed a meaningful rebound in Jumia’s growth metrics, nudging the stock higher. This article breaks down ...
Intel posted a stronger-than-expected Q1, yet rising costs and cash-flow strain raise the risk of a sharper pullback....
As PacBio lays out its Q1 2026 results, investors hunt for catalysts, cadence, and cash runway signals. This guide tr...
NVIDIA posted blockbuster results that reinforce its AI data center leadership, but the stock faces a rocky road as h...
Iran has replied to the latest U.S. ceasefire proposal via Pakistani mediators, demanding a permanent end to the war ...
UWM Holdings said its controlling shareholder terminated a rules-based stock-sale program intended to boost float and...
Investors are keen on LENZ as the company reports Q1 2026 earnings. This in-depth look breaks down the key numbers, w...
Netflix reports revenue growth driven by ads and a leaner strategy, while Disney posts margins and park revenue gains...